Arrowhead Pharmaceuticals Aktie
14,04
EUR
+0,19
EUR
+1,34
%
15,33
USD
+0,30
USD
+2,00
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
07.09.18 | Arrowhead Pharmaceuticals Buy | B. Riley FBR | |
06.09.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
08.08.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
02.07.18 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
09.05.18 | Arrowhead Pharmaceuticals Overweight | Cantor Fitzgerald | |
10.11.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets | |
19.05.16 | Arrowhead Pharmaceuticals Buy | Chardan Capital Markets |
Werbung
Werbung